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Here, we report the characterization of 122 Pseudomonas aeruginosa clinical isolates from three
distinct geographical locations: Dartmouth Hitchcock Medical Center in New Hampshire, USA,
the Charles T. Campbell Eye Microbiology Lab at the University of Pittsburgh Medical Center,
USA, and the Aravind Eye Hospital in Madurai, India. We identified and located clustered regularly
interspaced short palindromic repeats (CRISPR) in 45/122 clinical isolates and sequenced these
CRISPR, finding that Yersinia subtype CRISPR regions (33%) were more prevalent than the
Escherichia CRISPR region subtype (6%) in these P. aeruginosa clinical isolates. Further, we
observed 132 unique spacers from these 45 CRISPR that are 100% identical to prophages or
sequenced temperate bacteriophage capable of becoming prophages. Most intriguingly, all of
these 132 viral spacers matched to temperate bacteriophage/prophages capable of inserting into
the host chromosome, but not to extrachromosomally replicating lytic P. aeruginosa
bacteriophage. We next assessed the ability of the more prevalent Yersinia subtype CRISPR
regions to mediate resistance to bacteriophage infection or lysogeny by deleting the entire
CRISPR region from sequenced strain UCBPP-PA14 and six clinical isolates. We found no
change in CRISPR-mediated resistance to bacteriophage infection or lysogeny rate even for
CRISPR with spacers 100% identical to a region of the infecting bacteriophage. Lastly, to show
these CRISPR and cas genes were expressed and functional, we demonstrated production of
small CRISPR RNAs. This work provides both the first examination to our knowledge of CRISPR
regions within clinical P. aeruginosa isolates and a collection of defined CRISPR-positive and
-negative strains for further CRISPR and cas gene studies.
INTRODUCTION
The ability of mobile genetic elements to alter the fitness
and/or phenotype of bacteria has been well established
(Bru ¨ssow et al., 2004). Recent studies in members of the
genera Pseudomonas, Streptococcus and Staphylococcus have
demonstrated the importance of clustered regularly inter-
spaced short palindromic repeats (CRISPR) in the
interaction of bacteria and mobile genetic elements such
as plasmids and bacteriophage (Barrangou et al., 2007;
Marraffini & Sontheimer, 2008; Zegans et al., 2009).
CRISPR are found in 39 and 88% of sequenced bacterial
and archaeal genomes, respectively (van der Oost et al.,
2009). Previous studies have shown that CRISPR regions
have been categorized into eight distinct subtypes
(Escherichia, Yersinia, Neisseria, Desulfovibrio, Thermotoga,
Haloarcula, Apern and Mycobacterium) that are widely
distributed in bacteria and archaea (Haft et al., 2005).
CRISPR subtypes vary in both the sequence and length of
their identical repeats as well as their repertoire of CRISPR
associated (cas) genes (Haft et al., 2005). Many CRISPR and
their cognate cas genes are found in the same genomic
location, termed a CRISPR region (Zegans et al., 2009). So-
called generalcasgenes arefound inmultipleCRISPR region
subtypes (Haft et al., 2005). Only one cas gene is found in all
CRISPR region subtypes, namely the cas1 gene (Haft et al.,
2005). However, each of these regions also harbours
subtype-specific CRISPR-associated genes abbreviated csx,
Abbreviations: CRISPR, clustered regularly interspaced short pal-
indromic repeats; crRNA, CRISPR RNA; DHMC, Dartmouth Hitchcock
Medical Center; EOP, efficiency of plaquing; PAM, proto-spacer-
associated motifs.
A supplementary figure and five supplementary tables are available with
the online version of this paper.
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Yersinia subtype) (Haft et al., 2005). Most cas genes are not
shared between CRISPR region subtypes, calling into
question the ability of different CRISPR regions to function
similarly (Haft et al., 2005).
Previous studies have implicated CRISPR in the resistance
to lytic bacteriophage and plasmids (Barrangou et al., 2007;
Marraffini & Sontheimer, 2008). However, native resis-
tance to bacteriophage and plasmids has only been
observed in Streptococcus thermophilus and Staphylococcus
epidermidis, respectively (Barrangou et al., 2007; Brouns
et al., 2008; Marraffini & Sontheimer, 2008). While many
bioinformatic studies have been published which match
CRISPR spacer content to bacteriophage genomes (Dı ´ez-
Villasen ˜or et al., 2010; Held & Whitaker, 2009; Shah et al.,
2009; Vestergaard et al., 2008), few studies have attempted
to test the ability of these native CRISPR regions to mediate
functional bacteriophage–host interactions.
Here, we report the prevalence, location and sequence of
CRISPR regions from Pseudomonas aeruginosa clinical
isolates, thus providing a library of P. aeruginosa spacers
matching sequenced bacteriophages. We also report the
host range and contribution to resistance of these CRISPR
to sequenced P. aeruginosa bacteriophage. Finally, we show
that there is no evidence supporting a role for the Yersinia
subtype CRISPR in mediating native resistance to bac-
teriophage infection or lysogeny of P. aeruginosa.
METHODS
Bacterial and phage culture conditions. Bacterial strains,
bacteriophage strains, plasmids and primers used in this study are
listed in Supplementary Tables S1 and S2 (available with the online
version of this paper). P. aeruginosa and Escherichia coli strains were
routinely cultured in lysogeny broth (LB) at 37 uC (Bertani, 2004).
The minimal medium M63 was supplemented with MgSO4 (1 mM)
and arginine (0.4%).
Growth media were supplemented with antibiotics at the following
concentrations: ampicillin (Ap), 150 mgm l
21 (E. coli); gentamicin
(Gm),10 mgml
21(E.coli)an d50mgml
21(P.aeruginosa);carbenacillin
50 mgm l
21 (E. coli) and 500 mgm l
21 (P. aeruginosa).
Deletion of P. aeruginosa clinical isolate Yersinia subtype
CRISPR regions. Regions of sequence identity upstream and
downstream of the UCBPP-PA14 CRISPR region were amplified
and cloned into a pMQ30 vector, using Saccharomyces cerevisiae
recombineering as previously performed (Shanks et al., 2006).
Clinical P. aeruginosa isolates harbouring Yersinia subtype CRISPR
regions were spot mated with E. coli S17 harbouring the suicide
pMQ30-DCR plasmid. Transformants were selected on gentamicin
and nalidixic acid. Meridiploids were counter-selected on 5% sucrose
before being tested for the clean deletion of the entire CRISPR region
by PCR. Deletions were confirmed with primers csy3 amp For, csy3
amp Rev, DCR Check For(70) and DCR Check Rev(70). DCR Check
For(70) and DCR Check Rev(70) are located external to the regions of
DNA sequence homology found on plasmid pMQ30-DCR
(Supplementary Table S2). Primers csy3 amp For and csy3 amp Rev
were used to amplify csy3, providing both a positive and negative
control for each strain (Supplementary Table S2).
Northern blot analysis. Northern blot assays were performed to
determine the ability of P. aeruginosa strains to functionally produce
small CRISPR RNAs (crRNAs) under laboratory conditions. Cultures
grown overnight in LB medium were pelleted and resuspended in
100 ml4 0 0mgl y s o z y m em l
21 in TE buffer for 3–5 min at room
temperature. Following lysozyme-mediated cell lysis, total RNA was
purified using the mirVana miRNA isolation kit (Ambion),
essentially following the manufacturer’s instructions for total RNA
extraction. Primers Northern Marker/probe For and Northern
Marker/probe Rev2 were utilized in PCRs to synthesize a probe
comprising the last four spacers and three repeats of CRISPR2. The
random primed DNA labelling kit (Roche) and [a-
32P]dCTP [3000 Ci
mmol
21 (111 TBq mmol
21); PerkinElmer] were utilized according
to the manufacturer’s specification to radioactively label the probe.
mirVana-suggested sRNA prehybridization, hybridization and wash
solutions were utilized at 65, 37 and 37 uC, respectively. These
conditions were chosen because they allowed our probe, containing
four CRISPR spacers and three CRISPR repeats, to hybridize with
the conserved repeat sequence of all Yersinia subtype CRISPR-
derived small crRNAs regardless of spacer content. Following the
third 15 min wash, membranes were covered with plastic wrap and
exposed to a storage phosphor screen (GE Healthcare) overnight.
After exposure, phosphor screens were analysed on a Storm 860
(Molecular Devices) and processed using Image Quant software v5.2
(Molecular Devices).
Measurement of efficiency of plaquing (EOP). Bacteriophage
lysates were prepared by filter-sterilizing overnight LB-grown cultures
of either P. aeruginosa strains UCBPP-PA14 or PAO1 lysogenized by
the given temperate bacteriophage. Top agar lawns of CRISPR-
region-positive and -negative strains were prepared as described
previously (Zegans et al., 2009), and spotted with serial dilutions of
three independent bacteriophage preparations. The EOP was
determined by dividing the titre of a single bacteriophage preparation
on the CRISPR region deletion strain by the titre obtained on the
cognate CRISPR-region-positive strain. Standard deviations were
obtained by comparison of the EOP obtained for three independent
bacteriophage preparations.
Measurement of lysogeny frequency. Similar to EOP measure-
ments, bacteriophage lysates were prepared by filter-sterilizing
overnight LB-grown cultures of P. aeruginosa strain UCBPP-PA14
lysogenized by either DMS3 or MP22. Microcentrifuge tubes
containing 500 ml of sterile LB medium were inoculated with 10 ml
of an overnight culture of either wild-type P. aeruginosa UCBPP-
PA14 or the DCR mutant. This dilute bacterial culture was then
inoculated with 10 ml purified bacteriophage (10
7 p.f.u. ml
21) and
incubated at 37 uC for 25 min. Following incubation, cultures were
washed twice with fresh LB medium to remove all remaining
infectious bacteriophage particles. Serial dilutions were performed,
plated on LB agar and incubated overnight at 37 uC. Cross-streak test
plates were prepared by dripping 30 ml bacteriophage lysate down the
centre of an LB agar plate (Davis et al., 1980). Single colonies were
picked from plates and streaked perpendicularly across the central
bacteriophagelysatelineofthecross-streaktestplates.Bacteriathathad
become lysogens were immune to super-infection by the same
bacteriophage; however, non-infected bacteria grew poorly after
passing through the concentrated bacteriophage lysate (Davis et al.,
1980). Three independent assays were performed for each strain, with
50 colonies cross-streaked for every experiment (150 total colonies per
strain). Statistical analysis was performed using the Fischer exact test.
CRISPR region sequencing and annotation. Clinical isolates
harbouring Yersinia subtype CRISPR regions were amplified by PCR
with primers Yersinia subtype CR amp For(70) and Yersinia subtype
CR amp Rev(70) using Phusion polymerase (New England Biolabs,
Beverley, MA). The resulting ~12 kb product was gel purified
Pseudomonas CRISPR contain spacers against prophages
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DNA analyser sequencer using primers Yersinia subtype CRISPR1
SEQ FOR(70), Yersinia subtype CRISPR1 SEQ REV(70), Yersinia
subtype CRISPR2 SEQ FOR(70), and Yersinia subtype CRISPR2 SEQ
REV(70). Sequencing gaps were closed using unique primers
proximal or distal to the sequencing gap (primer sequences not
shown). Annotation of each CRISPR1 and 2 was performed manually
and entered into the redundant spacer library (Supplementary Table
S3, available with the online version of this paper).
Clinical isolates harbouring Escherichia subtype CRISPR regions were
treated similarly except primers Escherichia subtype CR amp For(72)
and Escherichia subtype CR amp Rev(72) were used to amplify the
~10 kb region and primers Escherichia subtype CRISPR1 SEQ
FOR(72), Escherichia subtype CRISPR1 SEQ REV(69), Escherichia
subtype CRISPR2 SEQ FOR(70), and Escherichia subtype CRISPR2
SEQ REV(72) were utilized in sequencing reactions.
Redundant and non-redundant spacer libraries. The spacer
content of each strain was entered into a redundant spacer library
(Supplementary Table S3). We also created a non-redundant library
in which each unique spacer was represented in the database only
once (Supplementary Table S4, available with the online version of
this paper). Each non-redundant spacer was then compared against
the NCBI database using BLASTN to identify all 100% identical spacer
targets using the program iSpacer (identify spacer).
iSpacer. iSpacer was created to increase the speed and accuracy at
which large spacer libraries can be compared to the NCBI sequence
database. iSpacer is written in the Python programming language, and
functions on both PC and Mac platforms. Spacer libraries in FASTA
format are opened in iSpacer, compared against the entire NCBI
database at various stringency levels, and the resulting proto-spacer
matches are exported into .txt and Microsoft Excel formatted files.
The iSpacer program and supporting material is available free upon
request from the corresponding author.
RESULTS
Prevalence and location of Pseudomonas
aeruginosa CRISPR regions
We determined the prevalence of Yersinia and Escherichia
subtype CRISPR regions in 122 clinical isolates of P.
aeruginosa from three distinct geographical locations. Fifty
isolates were obtained from Dartmouth Hitchcock Medical
Center (DHMC) (Lebanon, NH, USA), 43 were from the
Charles T. Campbell Eye Microbiology Lab (Pittsburgh,
PA, USA), and 29 were from Aravind Eye Hospital
(Madurai, Tamil Nadu, India). Isolates were obtained
from P. aeruginosa sputum, urine, cystic fibrosis, and eye
infections. Given the geographical and clinical diversity of
this collection, it was likely these isolates have experienced
a wide range of CRISPR–bacteriophage interactions.
To determine the prevalence of Yersinia and Escherichia
subtype CRISPR regions, we amplified the subtype-specific
cas genes csy1 and cse3, respectively. Primers specific for
csy1 and cse3 were verified on the only two sequenced P.
aeruginosa strains harbouring CRISPR regions (UCBPP-
PA14 and PA2192). The conserved non-CRISPR/cas
related gene pilG was utilized as a positive control for all
PCRs. Utilizing primers specific to P. aeruginosa strain
UCBPP-PA14 csy1 gene, we found that 40 of the 122
clinical isolates putatively harbour Yersinia subtype
CRISPR regions (33%). Campbell Eye Microbiology Lab
samples had a slightly higher Yersinia subtype prevalence
(42%) than those from DHMC or Aravind Eye Hospital
(22 and 38%, respectively). Initially we believed that these
CRISPR/cas regions would be randomly distributed in
different locations throughout the clinical isolate genomes
because CRISPR regions are thought to be highly mobile
genomic regions (Chakraborty et al., 2010). However, all
40 Yersinia subtype CRISPR regions we mapped were
located between homologues of the PA14_33290 and
PA14_33370 ORFs.
Likewise, primers specific to the P. aeruginosa strain
PA2192 cse3 gene led to the discovery of seven isolates
harbouring Escherichia subtype regions (6%). Escherichia
subtype CRISPR regions were found in 10% of Aravind
Eye Hospital isolates, while only 6 and 2% of DHMC
and Campbell Eye Microbiology Lab samples, respectively,
harboured these regions. Similar to the Yersinia subtype,
all Escherichia CRISPR regions were found in the same
genomic location, between the PA14_48160 and PA14_
48150 ORF.
Interestingly, sequenced P. aeruginosa strain PA2192 and
three of the seven clinical isolates harbouring an Escherichia
subtype CRISPR region also contain a Yersinia subtype
region.
While we believe that this PCR-based analysis of these
clinical isolates is thorough, we likely overlooked strongly
degenerate Yersinia and Escherichia subtype CRISPR
regions, as well as CRISPR regions of other subtypes.
CRISPR region conservation and spacer
sequence
Sequencing of CRISPR regions was accomplished by
amplification of the entire ~12 kb Yersinia and ~10 kb
Escherichia CRISPR regions by PCR (Fig. 1a), followed by
gel purification and sequencing of PCR products. Initially,
both cas genes and CRISPR were sequenced, but it was
quickly evident that cas sequence and organization were
well conserved with previously sequenced P. aeruginosa
strains UCBPP-PA14 and PA2192. Thus, the high conser-
vation of cas gene sequences prompted us to focus on
sequencing the more variable CRISPR sequences.
Intriguingly, both Yersinia and Escherichia CRISPR regions
have similar organizations. Both regions harbour two
CRISPR with slightly different repeat sequences flanking a
series of cas genes (Fig. 1b).
To analyse the spacer content of these strains, we sequenced
each CRISPR and created a redundant spacer library with
every spacer from all of the CRISPR-positive clinical isolates
analysed (Supplementary Table S3). In order to follow the
standard numbering system for CRISPR spacers presented
in Supplementary Table S3, we made the assumption based
K. C. Cady and others
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2008)thatspaceracquisitionispolar,takingplaceatoneend
of a given stretch of each CRISPR. Convention states that
spacers are numbered starting from the terminus where new
spacers are acquired (Deveau et al., 2008). The data used to
support the numbering system presented in Supplementary
Table S3 are presented in Supplementary Fig. S1 (available
with the online version of this paper). It is worth noting that
the most prevalent spacer repertoires for Yersinia and
Escherichia subtype CRISPR are similar to the CRISPR
spacer sequences found in P. aeruginosa strains UCBPP-
PA14 and 2192, respectively.
We also created a non-redundant library of all sequenced
spacers, which is presented in Supplementary Table S4. This
non-redundant spacer library contains 656 unique spacers,
which were independently compared against the NCBI
database. This comparison was performed using the newly
developed iSpacer program, which can compare large lists of
spacer sequences to the NCBI database using BLASTN,t o
determine regions of the bacterial and bacteriophage
genomes that are identical to spacer sequences.
The sequences identified by using iSpacer analysis could be
categorized into five groups, those spacers matching: (i)
sequenced lysogenic P. aeruginosa bacteriophage (n565), (ii)
prophages within sequenced P. aeruginosa clinical isolates
(n595), (iii) transposons (n52), (iv) pathogenicity islands
(n521), and (v) previously sequenced P. aeruginosa CRISPR
regions (Supplementary Table S4).
Among the spacers that showed 100% identity to non-
CRISPR sequences, 65 independent spacers were 100%
identical to portions of 12 sequenced, well-characterized
lysogenic P. aeruginosa bacteriophage. Fig. 2 illustrates the
location of spacers matching eight representative
sequenced bacteriophages: DMS3, MP22, D3112, D3,
PAJU2, B3, WCTX and F116 (Braid et al., 2004; Byrne &
Kropinski, 2005; Heo et al., 2007; Kropinski, 2000;
Nakayama et al., 1999; Uchiyama et al., 2009; Wang et al.,
2004; Zegans et al., 2009). Further, 95 unique spacers were
found to match uncharacterized prophages on the genomes
of P. aeruginosa clinical isolates. These prophages were
sequenced as part of bacterial genome sequencing projects
or obtained from metagenomic studies of cystic fibrosis
isolates (Hayden et al., 2008; Roy et al., 2010; Winstanley
et al., 2009). Interestingly, a number of these spacers
matched sequences of prophages linked to the increased
virulence of the Liverpool epidemic strain LESB58
(Supplementary Table S5) (Winstanley et al., 2009). Only
two spacers matched to transposons; oddly these spacers
were also the only spacers that matched to non-P.
aeruginosa sequences (these non-transposon matches were
not included in Supplementary Table S4). Two spacers
were also identical to pyocin gene fragments, which are
vestigial bacteriophage tail fibres used by P. aeruginosa to
puncture the membrane of competing organisms (Lee et al.,
1999).
We also identified 21 unique spacers that matched to P.
aeruginosa genomic islands (PAGI). Great care was taken to
differentiate spacer matches within putative lysogenic
bacteriophage genomes from those matching PAGI.
Twelve unique spacers were 100% homologous to PAGI-
6, of which five also matched to the WCTX genome, a
finding consistent with previous reports detailing the
sequence conservation between the mobile genomic island
PAGI-6 and the cytotoxin-encoding bacteriophage WCTX
(Battle et al., 2009). PAGI-5 and the P. aeruginosa UCBPP-
PA14 pathogenicity island 1 (PAPI-1) are members of a
large family of genomic islands closely related to large
integrating 103.5 kb pKLC102-like plasmids first discov-
ered in P. aeruginosa clone C strains (Battle et al., 2009).
Nine unique spacers matched to PAGI-5-like elements,
such as PAPI-1.
Fig. 1. Organization and conservation of P.
aeruginosa CRISPR regions. (a) Organization
of cas genes and flanking CRISPR are shown
for the Escherichia subtype (top) and Yersinia
subtype (bottom). Spacers are shown as
diamonds and repeats as rectangles. Arrows
indicate cas genes and their predicted direc-
tion of transcription. (b) Repeat sequences of
the Yersinia and Escherichia subtypes (differ-
ences are underlined).
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associated motifs (PAMs)
We analysed the flanking sequence of the putative proto-
spacers corresponding to the unique spacers identified here
(data not shown) and found conserved PAMs that were
different between Yersinia and Escherichia subtypes.
Yersinia subtypes contained a conserved GG dinucleotide
immediately adjacent to their spacer, while Escherichia
subtypes had a consensus CTT PAM. Both of these PAM
motifs matches those previously discovered using spacer
matches from many bacterial species containing the same
CRISPR subtype (Mojica et al., 2009). Our large library of
100% identical spacer matches also showed that PAGI,
prophages and previously sequenced bacteriophage all
retained the same PAM sequence for both CRISPR
subtypes (data not shown).
Analysis of CRISPR-mediated resistance using
EOP and lysogeny assays
Previous studies implicated CRISPR and cas genes in
resistance to lytic bacteriophages and to plasmids
(Barrangou et al., 2007; Marraffini & Sontheimer, 2008).
To test the ability of the more prevalent Yersinia subtype
CRISPR regions to mediate bacteriophage resistance, we
identified clinical isolates with CRISPR regions harbouring
one or more unique spacers 100% identical to sequenced
bacteriophage. We then created mutant strains lacking the
entire CRISPR region, and these deletion strains served as a
control for non-CRISPR-mediated interactions. We
assessed the resistance of each wild-type clinical isolate
and its CRISPR deletion derivative to bacteriophage
infection using an assay that measured the EOP.
Sequenced bacteriophage D3, DMS3, MP22 and F116 were
utilized to infect clinical isolates harbouring spacers 100%
identical to proto-spacer regions within the given bac-
teriophage. For most bacteriophages tested, we observed no
ability to plaque on the clinical strains tested regardless of
the presence or absence of the CRISPR region (Table 1).
For those strains that could support plaquing by DMS3
and/or MP22, we found no evidence for CRISPR-
dependent resistance to bacteriophage as judged by a
plaque assay (Table 1). That is, the EOP was approximately
1 in all experiments. These data indicate that for the strains
and bacteriophage tested, CRISPR did not confer resistance
to infection.
To determine if Yersinia subtype CRISPR regions harbour-
ing 100% identical spacer matches to temperate bacterio-
phage impact the rate at which lysogeny occurs, we tested
the frequency at which P. aeruginosa UCBPP-PA14 was
lysogenized by bacteriophages MP22 and DMS3 in the
presence or absence of the Yersinia subtype CRISPR region
(harbouring one or more spacers 100% identical to these
bacteriophage). We observed, by cross-streak test, that 8%
of CRISPR-positive bacteria and 6% of DCR bacteria
became lysogenized by bacteriophage DMS3. Similarly, 2%
of CRISPR-positive and 1.3% of DCR bacteria were
lysogenized by the MP22 bacteriophage. Both of these
lysogeny rates were not found to be significantly different
Fig. 2. Location of spacers 100% identical to
common temperate P. aeruginosa bacterio-
phage. Boxes denote known or putative
bacteriophage ORFs that have been published
previously. Forward oriented ORFs are
depicted above those ORFs that are diver-
gently transcribed. Each arrow signifies the
site of a proto-spacer sequence 100%
identical to a spacer identified in our analysis,
with Yersinia subtype spacer matches shown
as black triangles and Escherichia subtype
spacer matche shown as open triangles.
Table 1. Measuring EOP of clinical isolates
EOP is given as mean±SD. EOP of 1 indicates no change in resistance.
NCR, Non-CRISPR-mediated resistance, assessed by the lack of
plaque formation in the CRISPR-negative clinical isolate.
Strain Bacteriophage EOP
PA14 DCR DMS3 1.06±0.2
MP22 1.95±1.0
F116 NCR
SMC4485 DCR DMS3 1.53±0.5
MP22 2.10±1.6
F116 NCR
SMC4515 DCR MP22 0.92±0.3
F116 NCR
SMC4513 DCR DMS3 NCR
SMC4384 DCR D3 NCR
SMC4502 DCR DMS3 NCR
SMC4504 DCR F116 NCR
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Fisher exact test (P50.65 and P51, respectively).
crRNA production from clinical isolates
We next assessed whether the CRISPR transcript in the
clinical isolates described above were processed into small
RNAs. From the presence of crRNA we could infer that the
cas genes were expressed and each product(s) was
functional (Haurwitz et al., 2010). Northern blot analysis
showed that each strain produced crRNAs, and the
production of these crRNAs was dependent on the
presence of the CRISPR region (Fig. 3). These data indicate
that Yersinia subtype P. aeruginosa CRISPR regions are
expressed and functionally able to produce crRNAs under
our experimental conditions.
DISCUSSION
This work demonstrates that P. aeruginosa Yersinia subtype
CRISPR did not mediate native resistance to bacterio-
phages, even when the bacteriophages contained sequences
that were 100% identical to spacers within the CRISPR.
Widely accepted CRISPR dogma would suggest that when
challenged by the bacteriophage with sequences 100%
identical to spacers, these CRISPR regions should respond
by mediating resistance to the given bacteriophage
(Barrangou et al., 2007). To test this model with the
Yersinia subtype CRISPR, we analysed multiple clinical
isolates harbouring a diverse range of spacers against a
collection of sequenced P. aeruginosa bacteriophage.
However, we found that of the seven strains tested, none
mediated CRISPR-dependent resistance to bacteriophage.
Further, P. aeruginosa strain UCBPP-PA14, which har-
bours spacers 100% identical to bacteriophage MP22 and
DMS3, showed no difference in the rate of lysogeny for
either of these temperate bacteriophage in the wild-type
versus DCR strains. Thus, two of the previously described
host–bacteriophage interactions mediated by CRISPR
(Barrangou et al., 2007; Edgar & Qimron, 2010) are not
impacted by the Yersinia subtype CRISPR region. The
observation that Yersinia subtype CRISPR regions pro-
duced small crRNA in all of the strains tested demonstrates
that these regions are functional under our laboratory
conditions. Thus, our findings argue against the conclusion
that these regions are ‘silent’, as has been suggested for
CRISPR regions within E. coli (Dı ´ez-Villasen ˜or et al., 2010;
Pougach et al., 2010; Westra et al., 2010).
While previous studies of other CRISPR region subtypes
have reported the importance of short PAM motifs
adjacent to the bacteriophage genomic sequence matching
to CRISPR region spacers (proto-spacers) (Deveau et al.,
2008), no study has demonstrated their requirement in
Yersinia subtype CRISPR-mediated interactions. Our
analysis of bacteriophage MP22 demonstrated no
CRISPR-dependent alteration in EOP or frequency of
lysogeny when the bacterial host strain harbours a spacer
100% identical to a bacteriophage proto-spacer with a
conserved PAM. Unfortunately, in this work we did not
observe any CRISPR-dependent alteration in lysogeny rate
or bacteriophage resistance, and so cannot comment on the
requirement of the PAM motifs in our studies.
Our analysis showed that the Yersinia and Escherichia
subtype CRISPR regions of P. aeruginosa clinical isolates
harbour spacers against mobile genetic elements that
integrate within the host chromosome. All 132 unique
spacers 100% identical to viral sequences match to either
well-studied temperate P. aeruginosa bacteriophage capable
of integrating into the host chromosome or prophages
within the genome of P. aeruginosa clinical isolates (Braid
et al., 2004; Byrne & Kropinski, 2005; Heo et al., 2007;
Kropinski, 2000; Lee et al., 1999; Nakayama et al., 1999;
Roy et al., 2010; Uchiyama et al., 2009; Wang et al., 2004;
Winstanley et al., 2009; Zegans et al., 2009). We also
identified additional spacer sequences that match PAGI
and transposons. Spacers matching to extrachromosomally
replicating bacteriophage, which is typical of lytic bac-
teriophage, and plasmids are conspicuously absent from
our dataset. Our data are also consistent with a previous
report describing Escherichia and Yersinia subtype CRISPR
regions which stated that of 100 E. coli strains tested,
65.4% of bacteriophage-targeting spacers corresponded to
a prophage within the E. coli isolates E24377A and SE11
(Dı ´ez-Villasen ˜or et al., 2010). This seemingly preferential
targeting of prophages coupled with spacers matching to
PAGI and transposons raises the possibility that the natural
role of these CRISPR regions is in the interaction with
chromosomally integrated mobile genetic elements rather
than in mediating defence against extra-chromosomal
infecting bacteriophages and plasmids.
How different CRISPR region subtypes interact with proto-
spacer targets is an area of active research and speculation.
However, when one considers that cas1, which is thought
to insert new spacers, is the only cas gene found in all
CRISPR subtypes it is perhaps less surprising that these
regions may have been co-opted for varied roles in
Fig. 3. Characterization of CRISPR-positive and -negative P.
aeruginosa clinical isolates. Northern blot analysis of small crRNA
production for the wild-type lab strain and six clinical isolates (left)
and their DCRISPR derivatives (right). In this experiment, the three
spacers and two repeats closest to the cas1 gene of CRISPR2 of
P. aeruginosa UCBPP-PA14 were used as the probe.
Pseudomonas CRISPR contain spacers against prophages
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that the Neisseria subtype CRISPR region of Streptococcus
thermophilus is believed to interact with the DNA of
invading bacteriophage, while the Thermotoga subtype of
Pyrococcus furiosus has been shown to interact directly with
RNA (Hale et al., 2009).
We found 41 unique clinical P. aeruginosa CRISPR spacers
100% identical to known horizontally transferable virulence
factors, as well as 112 spacers identical to other putative
virulence factors within PAGI, prophages and lysogenic
bacteriophage.Transposons,prophages and genomicislands
are thought to be responsible for the majority of strain
diversity in P. aeruginosa (Battle et al., 2008, 2009;
Winstanley et al., 2009). This type of genomic diversity is
perhaps best exemplified by the Liverpool epidemic strain of
P. aeruginosa (strain LESB58). Prior to this LESB58 study, it
was assumed that most P. aeruginosa strains had very similar
genomic content and few unique virulence factors that
would make one strain considerably more virulent than
another. However, unbiased signature-tagged mutagenesis
coupled with genome sequencing revealed that many of the
strain-specific genomic islands and prophages within strain
LESB58 were critical to the increased virulence of this strain
of P. aeruginosa (Winstanley et al., 2009). Strikingly, three of
the four prophage genomes implicated in contributing to
LESB58 virulence in a chronic rat lung model of infection
were targeted by one or more unique spacers within our
library. Similarly, we identified many unique spacers
targeting the previously identified virulence-modulating
lysogenic P. aeruginosa bacteriophages D3 and WCTX. In
addition, nine unique spacers targeted PAGI-5/PAPI-I-like
elements, which have been shown to contribute to the
virulence of P. aeruginosa clinical isolate PSE9 within
the mouse model of acute pneumonia (Battle et al., 2008).
The observation that human clinical isolates of P. aeruginosa
have acquired and retained spacers 100% identical to
known and putative chromosomal virulence factors raises
the intriguing hypothesis that these CRISPR and cas genes
are mediating a clinically important interaction between the
bacterial host and mobile genetic elements.
ACKNOWLEDGEMENTS
We thank Rory T. Allar, Dae Gon Ha and Thomas Hampton for
preliminary experiments or statistical analysis. Bacteriophage or
bacteria strains were contributed by the Cho lab (Sogang University,
South Korea), Collection de phages Fe ´lix d’Herelle (Universite ´ Laval,
France), the Maillard lab (Cardiff University, UK), the Lory Lab
(Harvard Medical School, USA) and the Charles T. Campbell Eye
Microbiology Lab (University of Pittsburgh, USA). This work was
supported by a National Institutes of Health predoctoral fellowship to
K.C.C. (T32 AI007519), the Dartmouth Dickey Center, and National
Institutes of Health grants R01AI083256 and R21AI068662 to G.A.O.
REFERENCES
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P.,
Moineau, S., Romero, D. & Horvath, P. (2007). CRISPR provides
acquired resistance against viruses in prokaryotes. Science 315, 1709–
1712.
Battle, S. E., Meyer, F., Rello, J., Kung, V. & Hauser, A. (2008). Hybrid
pathogenicity island PAGI-5 contributes to the highly virulent
phenotype of a Pseudomonas aeruginosa isolate in mammals.
J Bacteriol 190, 7130–7140.
Battle, S. E., Rello, J. & Hauser, A. (2009). Genomic islands of
Pseudomonas aeruginosa. FEMS Microbiol Lett 290, 70–78.
Bertani, G. (2004). Lysogeny at mid-twentieth century: P1, P2, and
other experimental systems. J Bacteriol 186, 595–600.
Braid, M. D., Silhavy, J., Kitts, C., Cano, R. & Howe, M. (2004).
Complete genomic sequence of bacteriophage B3, a Mu-like phage of
Pseudomonas aeruginosa. J Bacteriol 186, 6560–6574.
Brouns, S. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J.,
Snijders, A. P., Dickman, M. J., Makarova, K. S., Koonin, E. V. & van
der Oost, J. (2008). Small CRISPR RNAs guide antiviral defense in
prokaryotes. Science 321, 960–964.
Bru ¨ssow, H., Canchaya, C. & Hardt, W. (2004). Phages and the
evolution of bacterial pathogens: from genomic rearrangements to
lysogenic conversion. Microbiol Mol Biol Rev 68, 560–602.
Byrne, M. & Kropinski, A. (2005). The genome of the Pseudomonas
aeruginosa generalized transducing bacteriophage F116. Gene 346,
187–194.
Chakraborty, S., Snijders, A., Chakravorty, R., Ahmed, M., Tarek, A. &
Hossain, M. (2010). Comparative network clustering of direct repeats
(DRs) and cas genes confirms the possibility of the horizontal transfer
of CRISPR locus among bacteria. Mol Phylogenet Evol 56, 878–887.
Davis, R., Botstein, D. & Roth, J. (1980). Advanced Bacterial Genetics.
Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Deveau, H., Barrangou, R., Garneau, J., Labonte ´, J., Fremaux, C.,
Boyaval, P., Romero, D., Horvath, P. & Moineau, S. (2008). Phage
response to CRISPR-encoded resistance in Streptococcus thermophilus.
J Bacteriol 190, 1390–1400.
Dı ´ez-Villasen ˜or, C., Almendros, C., Garcı ´a-Martı ´nez, J. & Mojica, F.
(2010). Diversity of CRISPR loci in Escherichia coli. Microbiology 156,
1351–1361.
Edgar, R. & Qimron, U. (2010). The Escherichia coli CRISPR system
protects from llysogenization, lysogens, and prophage induction.
J Bacteriol 192, 6291–6294.
Haft, D. H., Selengut, J., Mongodin, E. & Nelson, K. (2005). A guild of
45 CRISPR-associated (Cas) protein families and multiple CRISPR/
Cas subtypes exist in prokaryotic genomes. PLOS Comput Biol 1, e60.
Hale, C. R., Zhao, P., Olson, S., Duff, M., Graveley, B., Wells, L.,
Terns, R. & Terns, M. (2009). RNA-guided RNA cleavage by a CRISPR
RNA-Cas protein complex. Cell 139, 945–956.
Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K. & Doudna, J.
(2010). Sequence- and structure-specific RNA processing by a
CRISPR endonuclease. Science 329, 1355–1358.
Hayden, H. S., Gillett, W., Saenphimmachak, C., Lim, R., Zhou, Y.,
Jacobs, M. A., Chang, J., Rohmer, L., D’Argenio, D. A. & other authors
(2008). Large-insert genome analysis technology detects structural
variation in Pseudomonas aeruginosa clinical strains from cystic
fibrosis patients. Genomics 91, 530–537.
Held, N. L. & Whitaker, R. (2009). Viral biogeography revealed by
signatures in Sulfolobus islandicus genomes. Environ Microbiol 11,
457–466.
Heo, Y. J., Chung, I., Choi, K., Lau, G. & Cho, Y. (2007). Genome
sequence comparison and superinfection between two related
Pseudomonas aeruginosa phages, D3112 and MP22. Microbiology
153, 2885–2895.
K. C. Cady and others
436 Microbiology 157Kropinski, A. M. (2000). Sequence of the genome of the temperate,
serotype-converting, Pseudomonas aeruginosa bacteriophage D3.
J Bacteriol 182, 6066–6074.
Lee, F. K., Dudas, K., Hanson, J.,Nelson, M., LoVerde,P. & Apicella, M.
(1999). The R-type pyocin of Pseudomonas aeruginosa Ci sa
bacteriophage tail-like particle that contains single-stranded DNA.
Infect Immun 67, 717–725.
Marraffini, L. A. & Sontheimer, E. (2008). CRISPR interference limits
horizontal gene transfer in staphylococci by targeting DNA. Science
322, 1843–1845.
Mojica, F. J., Dı ´ez-Villasen ˜or, C., Garcı ´a-Martı ´nez, J. & Almendros, C.
(2009). Short motif sequences determine the targets of the
prokaryotic CRISPR defence system. Microbiology 155, 733–740.
Nakayama, K., Kanaya, S., Ohnishi, M., Terawaki, Y. & Hayashi, T.
(1999). The complete nucleotide sequence of phi CTX, a cytotoxin-
converting phage of Pseudomonas aeruginosa: implications for phage
evolution and horizontal gene transfer via bacteriophages. Mol
Microbiol 31, 399–419.
Pougach, K., Semenova, E., Bogdanova, E., Datsenko, K.,
Djordjevic, M., Wanner, B. & Severinov, K. (2010). Transcription,
processing and function of CRISPR cassettes in Escherichia coli. Mol
Microbiol 77, 1367–1379.
Roy, P. H., Tetu, S., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q.,
Dodson, R., Harkins, D., Shay, R. & other authors (2010). Complete
genome sequence of the multiresistant taxonomic outlier
Pseudomonas aeruginosa PA7. PLoS ONE 5, e8842.
Shah, S. A., Hansen, N. & Garrett, R. (2009). Distribution of CRISPR
spacer matches in viruses and plasmids of crenarchaeal acidothermo-
philes and implications for their inhibitory mechanism. Biochem Soc
Trans 37, 23–28.
Shanks, R. M., Caiazza, N., Hinsa, S., Toutain, C. & O’Toole, G.
(2006). Saccharomyces cerevisiae-based molecular tool kit for
manipulation of genes from gram-negative bacteria. Appl Environ
Microbiol 72, 5027–5036.
Uchiyama, J., Rashel, M., Matsumoto,T., Sumiyama, Y., Wakiguchi, H.
& Matsuzaki, S. (2009). Characteristics of a novel Pseudomonas
aeruginosa bacteriophage, PAJU2, which is genetically related to
bacteriophage D3. Virus Res 139, 131–134.
van der Oost, J., Jore, M., Westra, E., Lundgren, M. & Brouns, S.
(2009). CRISPR-based adaptive and heritable immunity in prokar-
yotes. Trends Biochem Sci 34, 401–407.
Vestergaard, G., Shah, S., Bize, A., Reitberger, W., Reuter, M.,
Phan, H., Briegel, A., Rachel, R., Garrett, R. A. & Prangishvili, D.
(2008). Stygiolobus rod-shaped virus and the interplay of crenarch-
aeal rudiviruses with the CRISPR antiviral system. J Bacteriol 190,
6837–6845.
Wang, P. W., Chu, L. & Guttman, D. (2004). Complete sequence and
evolutionary genomic analysis of the Pseudomonas aeruginosa
transposable bacteriophage D3112. J Bacteriol 186, 400–410.
Westra, E. R., Pul, U., Heidrich, N., Jore, M. M., Lundgren, M.,
Stratmann, T., Wurm, R., Raine, A., Mescher, M. & other authors
(2010). H-NS mediated repression of CRISPR-based immunity in
Escherichia coli K12 can be relieved by the transcription activator
LeuO. Mol Microbiol 77, 1380–1393.
Winstanley, C., Langille, M., Fothergill, J., Kukavica-Ibrulj, I., Paradis-
Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A.
& other authors (2009). Newly introduced genomic prophage islands
are critical determinants of in vivo competitiveness in the Liverpool
Epidemic Strain of Pseudomonas aeruginosa. Genome Res 19, 12–23.
Zegans, M. E., Wagner, J., Cady, K., Murphy, D., Hammond, J. &
O’Toole, G. (2009). Interaction between bacteriophage DMS3 and
host CRISPR region inhibits group behaviors of Pseudomonas
aeruginosa. J Bacteriol 191, 210–219.
Edited by: S. D. Bentley
Pseudomonas CRISPR contain spacers against prophages
http://mic.sgmjournals.org 437